arrow
S

Susana Monge

institute of health carlos iii
H指数:29
被引数:3,245

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of the causal odds ratio in test-negative-design studies of COVID-19 vaccine effectiveness

在COVID-19疫苗有效性研究中识别因果优势比(test-negative-design研究)

2026-04-010
PRE
Unmeasured confounding and misclassification in studies estimating vaccine effectiveness against hospitalisation and death using electronic health records (EHRs): an evaluation of a multi-country European retrospective cohort study

未测量混杂和错分偏倚在利用电子健康记录(EHRs)评估疫苗对住院和死亡的保护效果研究中的影响:一项多国欧洲回顾性队列研究的评估

2025-12-170
OAAI
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

2023年秋季XBB.1.5 COVID-19加强针在2024年夏季于欧盟/欧洲经济区内的有效性:一项VEBIS电子健康记录网络研究

2025-11-280
OAAI
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024–May 2025

COVID-19疫苗在老年人群中的住院防护效果,欧洲VEBIS医院网络,2024年9月–2025年5月

2025-11-250
OAAI
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

关于接种后时间对疫苗效力估计与报告的建议:一项COVID-19病例研究

2025-11-170
OA
Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain

2023/24年西班牙秋冬COVID-19疫苗剂量在冬季和夏季浪潮中的有效性

2025-10-260
OAAI
Establishing Epidemic and Intensity Thresholds After a Major Change in Respiratory Virus Surveillance in Spain in 2020

2020年西班牙呼吸道病毒监测发生重大变化后,建立流行病和强度阈值

2025-09-220
PREAI
Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study

JN.1单价COVID-19疫苗接种在欧盟/欧洲经济区国家(2024年10月至2025年1月)的有效性:一项VEBIS电子健康记录网络研究

Vaccine
IF3.5
2025-09-190
PRE
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population

由于一般人群中SARS-CoV-2测试的可用性,在初级保健水平的新型冠状病毒肺炎疫苗有效性研究中引入了潜在的偏差

2025-08-012
OA
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network

欧洲目标人群中针对需要医疗干预的SARS-CoV-2症状性感染的COVID-19疫苗有效性(2024年10月至2025年1月,VEBIS初级保健网络)

2025-05-210
OA
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23

2022/23年度在VEBIS-EHR网络中针对秋季加强针的两种COVID-19疫苗有效性估计方法的比较

2025-03-172
OAAI
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
2024-11-251
OA
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years

在 ≥ 65岁的住院成年人中,呼吸道合胞病毒与SARS-CoV-2和流感的严重程度比较

2024-11-010
OAAI
Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022
2024-08-221
OAAI